{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:45:49Z","timestamp":1789749949753,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["No. 2023-I2M-C&T-B-102"],"award-info":[{"award-number":["No. 2023-I2M-C&T-B-102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-12034-w","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:58Z","timestamp":1759403458000},"page":"2876-2891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intratumoral heterogeneity of CT enhancement for component prediction and prognostic significance in combined hepatocellular carcinoma\u2011cholangiocarcinoma"],"prefix":"10.1007","volume":"36","author":[{"given":"Wei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4511-4736","authenticated-orcid":false,"given":"Xinming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"12034_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","volume":"74","author":"A Beaufrere","year":"2021","unstructured":"Beaufrere A, Calderaro J, Paradis V (2021) Combined hepatocellular-cholangiocarcinoma: an update. J Hepatol 74:1212\u20131224","journal-title":"J Hepatol"},{"key":"12034_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s11547-023-01726-2","volume":"128","author":"C Zheng","year":"2023","unstructured":"Zheng C, Gu XT, Huang XL et al (2023) Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study. Radiol Med 128:1460\u20131471","journal-title":"Radiol Med"},{"key":"12034_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100745","volume":"5","author":"M Claasen","year":"2023","unstructured":"Claasen M, Ivanics T, Beumer BR et al (2023) An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma(\u2606). JHEP Rep 5:100745","journal-title":"JHEP Rep"},{"key":"12034_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/his.14384","volume":"79","author":"CC Yen","year":"2021","unstructured":"Yen CC, Yen CJ, Shan YS et al (2021) Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification. Histopathology 79:556\u2013572","journal-title":"Histopathology"},{"key":"12034_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000530700","volume":"13","author":"L Ye","year":"2024","unstructured":"Ye L, Schneider JS, Ben Khaled N et al (2024) Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management. Liver Cancer 13:6\u201328","journal-title":"Liver Cancer"},{"key":"12034_CR6","doi-asserted-by":"publisher","first-page":"6397","DOI":"10.1007\/s00330-020-07656-1","volume":"31","author":"J Yang","year":"2021","unstructured":"Yang J, Huang JY, Chen X et al (2021) Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient\u2019s survival?. Eur Radiol 31:6397\u20136405","journal-title":"Eur Radiol"},{"key":"12034_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11547-023-01682-x","volume":"128","author":"R Sheng","year":"2023","unstructured":"Sheng R, Yang C, Zhang Y et al (2023) The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value. Radiol Med 128:1047\u20131060","journal-title":"Radiol Med"},{"key":"12034_CR8","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00330-022-09131-5","volume":"33","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Zheng X, Zhou C et al (2023) Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. Eur Radiol 33:1412\u20131421","journal-title":"Eur Radiol"},{"key":"12034_CR9","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1007\/s00330-022-09065-y","volume":"32","author":"C Zhou","year":"2022","unstructured":"Zhou C, Lu X, Wang Y et al (2022) Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. Eur Radiol 32:6702\u20136711","journal-title":"Eur Radiol"},{"key":"12034_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jmri.25568","volume":"46","author":"SH Park","year":"2017","unstructured":"Park SH, Lee SS, Yu E et al (2017) Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis. J Magn Reson Imaging 46:267\u2013280","journal-title":"J Magn Reson Imaging"},{"key":"12034_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/jjco\/hyaf029","volume":"55","author":"T Terashima","year":"2025","unstructured":"Terashima T, Harada K, Yamashita T (2025) Diagnosis, clinical characteristics, and treatment of combined hepatocellular-cholangiocarcinoma. Jpn J Clin Oncol 55:327\u2013333","journal-title":"Jpn J Clin Oncol"},{"key":"12034_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43749-3","volume":"14","author":"J Calderaro","year":"2023","unstructured":"Calderaro J, Ghaffari Laleh N, Zeng Q et al (2023) Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma. Nat Commun 14:8290","journal-title":"Nat Commun"},{"key":"12034_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00432-024-05781-8","volume":"150","author":"S Gurzu","year":"2024","unstructured":"Gurzu S, Szodorai R, Jung I et al (2024) Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies. J Cancer Res Clin Oncol 150:270","journal-title":"J Cancer Res Clin Oncol"},{"key":"12034_CR14","doi-asserted-by":"publisher","first-page":"9479","DOI":"10.1007\/s00330-021-07984-w","volume":"31","author":"SH Choi","year":"2021","unstructured":"Choi SH, Jeon SK, Lee SS et al (2021) Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI. Eur Radiol 31:9479\u20139488","journal-title":"Eur Radiol"},{"key":"12034_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00261-023-04174-8","volume":"49","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Huang P, Zhang Y et al (2024) Component prediction in combined hepatocellular carcinoma-cholangiocarcinoma: habitat imaging and its biologic underpinnings. Abdom Radiol (NY) 49:1063\u20131073","journal-title":"Abdom Radiol (NY)"},{"key":"12034_CR16","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.230118","volume":"6","author":"O Prior","year":"2024","unstructured":"Prior O, Macarro C, Navarro V et al (2024) Identification of precise 3D CT radiomics for habitat computation by machine learning in Cancer. Radiol Artif Intell 6:e230118","journal-title":"Radiol Artif Intell"},{"key":"12034_CR17","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1148\/radiol.2017170845","volume":"287","author":"J Juan-Albarracin","year":"2018","unstructured":"Juan-Albarracin J, Fuster-Garcia E, Perez-Girbes A et al (2018) Glioblastoma: vascular habitats detected at preoperative dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging predict survival. Radiology 287:944\u2013954","journal-title":"Radiology"},{"key":"12034_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00330-021-08204-1","volume":"32","author":"DH Lee","year":"2022","unstructured":"Lee DH, Park JE, Kim N et al (2022) Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery. Eur Radiol 32:497\u2013507","journal-title":"Eur Radiol"},{"key":"12034_CR19","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi Z, Huang X, Cheng Z et al (2023) MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology 308:e222830","journal-title":"Radiology"},{"key":"12034_CR20","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s00330-024-11172-x","volume":"35","author":"P Xie","year":"2024","unstructured":"Xie P, Huang Q, Zheng L et al (2024) Sub-region based histogram analysis of amide proton transfer-weighted MRI for predicting tumor budding grade in rectal adenocarcinoma: a prospective study. Eur Radiol 35:1382\u20131393","journal-title":"Eur Radiol"},{"key":"12034_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver Imaging Reporting and Data System (LI-RADS) Version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816\u2013830","journal-title":"Radiology"},{"key":"12034_CR22","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1007\/s00330-022-08691-w","volume":"32","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhu GQ, Zhou CW et al (2022) Risk stratification of LI-RADS M and LI-RADS 4\/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors. Eur Radiol 32:5166\u20135178","journal-title":"Eur Radiol"},{"key":"12034_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00330-021-08188-y","volume":"32","author":"C Zhou","year":"2022","unstructured":"Zhou C, Wang Y, Ma L et al (2022) Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis. Eur Radiol 32:78\u201388","journal-title":"Eur Radiol"},{"key":"12034_CR24","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s00330-023-10339-2","volume":"34","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen J, Yang C et al (2023) Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging\u2013based habitat imaging. Eur Radiol 34:3215\u20133225","journal-title":"Eur Radiol"},{"key":"12034_CR25","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2147\/JHC.S491243","volume":"18","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Yang C, Zeng M et al (2024) Prognostic impact of CCA components in combined hepatocellular carcinoma-cholangiocarcinoma. J Hepatocell Carcinoma 11:2483\u20132492","journal-title":"J Hepatocell Carcinoma"},{"key":"12034_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiol.2017170554","volume":"286","author":"A Tang","year":"2018","unstructured":"Tang A, Bashir MR, Corwin MT et al (2018) Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 286:29\u201348","journal-title":"Radiology"},{"key":"12034_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/JHC.S325686","volume":"8","author":"C Zhou","year":"2021","unstructured":"Zhou C, Ni X, Lu X et al (2021) MR features based on LI-RADS Ver. 2018 correlated with cytokeratin 19 expression in combined hepatocellular carcinoma-cholangiocarcinoma. J Hepatocell Carcinoma 8:975\u2013983","journal-title":"J Hepatocell Carcinoma"},{"key":"12034_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00330-018-5605-x","volume":"29","author":"SK Jeon","year":"2019","unstructured":"Jeon SK, Joo I, Lee DH et al (2019) Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiol 29:373\u2013382","journal-title":"Eur Radiol"},{"key":"12034_CR29","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00261-024-04194-y","volume":"49","author":"C Zhou","year":"2024","unstructured":"Zhou C, Huang P, Wu F et al (2024) How to differentiate between combined hepatocellular carcinoma-cholangiocarcinoma and intrahepatic cholangiocarcinoma with rim arterial phase hyperenhancement?. Abdom Radiol (NY) 49:3015\u20133023","journal-title":"Abdom Radiol (NY)"},{"key":"12034_CR30","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1007\/s00261-015-0352-9","volume":"40","author":"S Tsunematsu","year":"2015","unstructured":"Tsunematsu S, Chuma M, Kamiyama T et al (2015) Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma. Abdom Imaging 40:1492\u20131499","journal-title":"Abdom Imaging"},{"key":"12034_CR31","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.jhep.2013.02.013","volume":"58","author":"M Iavarone","year":"2013","unstructured":"Iavarone M, Piscaglia F, Vavassori S et al (2013) Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. J Hepatol 58:1188\u20131193","journal-title":"J Hepatol"},{"key":"12034_CR32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.prp.2018.06.011","volume":"214","author":"H Bosmuller","year":"2018","unstructured":"Bosmuller H, Pfefferle V, Bittar Z et al (2018) Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Pathol Res Pract 214:1136\u20131141","journal-title":"Pathol Res Pract"},{"key":"12034_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s13402-025-01041-0","volume":"48","author":"M Wu","year":"2025","unstructured":"Wu M, Que Z, Lai S et al (2025) Predicting the early therapeutic response to hepatic artery infusion chemotherapy in patients with unresectable HCC using a contrast-enhanced computed tomography-based habitat radiomics model: a multi-center retrospective study. Cell Oncol 48:709\u2013723","journal-title":"Cell Oncol"},{"key":"12034_CR34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s11547-023-01695-6","volume":"128","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang C, Sheng R et al (2023) Predicting the recurrence of hepatocellular carcinoma (\u2264\u20095 cm) after resection surgery with promising risk factors: habitat fraction of tumor and its peritumoral micro-environment. Radiol Med 128:1181\u20131191","journal-title":"Radiol Med"},{"key":"12034_CR35","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/jmri.29523","volume":"61","author":"C Wang","year":"2024","unstructured":"Wang C, Wu F, Wang F et al (2024) The association between tumor radiomic analysis and peritumor habitat-derived radiomic analysis on gadoxetate disodium-enhanced MRI with microvascular invasion in hepatocellular carcinoma. J Magn Reson Imaging 61:1428\u20131439","journal-title":"J Magn Reson Imaging"},{"key":"12034_CR36","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1002\/hep.26762","volume":"59","author":"AE Sirica","year":"2014","unstructured":"Sirica AE, Gores GJ (2014) Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting. Hepatology 59:2397\u20132402","journal-title":"Hepatology"},{"key":"12034_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1158\/1078-0432.CCR-21-1219","volume":"28","author":"CT Nguyen","year":"2022","unstructured":"Nguyen CT, Caruso S, Maille P et al (2022) Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy. Clin Cancer Res 28:540\u2013551","journal-title":"Clin Cancer Res"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12034-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12034-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:19:46Z","timestamp":1774883986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12034-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["12034"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12034-w","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Xinming Zhao.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Yongjian Zhu, one of our authors, is an expert in statistical analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained (No. 24\/241-3742).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The cohort used in this study was first reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}